Implications of 2001 cholesterol treatment guidelines based on a retrospective analysis of a high-risk patient cohort

American Journal of Cardiology

Volumn 89, Issue 6, 2002, Pages 765-766

  Frolkis, Joseph P ^a   Pearce, Gregory L ^a   Sprecher, Dennis L ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Preventive Cardiology and Rehabilitation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; POPULATION RESEARCH; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; RISK FACTOR; SHORT SURVEY;

EID: 0037085953     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)02351-7     Document Type: Article

References (6)

1. Executive summary of the third report of the National Cholesterol Education Program (NCEP)
2. Maximizing the cost-effectiveness of lipid-lowering therapy
3. Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics
4. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS
5. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events